FdaApplication

ANDA 216385

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2023-04-14

Products (1)

ProductActive ingredientStrengthDosage form
NITROFURANTOINNITROFURANTOIN25MG/5MLSUSPENSION;ORAL

1 product